The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer

Canadian Journal of Urology

Volumn 17, Issue 2, 2010, Pages 5077-5081

  Karnwal, Abhishek ^a   Venegas, Rose ^a   Shuch, Brian ^a,b   Bassett, Jeffrey ^a,b   Rajfer, Jacob ^a,b   Reznichek, Richard ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bladder cancer; Cystoscopy; Cytology; Fluorescence in situ hybridization; UroVysion

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; COMPARATIVE STUDY; CYSTOSCOPY; CYTOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGED; CYSTOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; URINE;

EID: 77956198712     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Black PC, Brown GA, Dinney CP. Molecular markers of urothelial cancer and their use in the monitoring of superfi cial urothelial cancer. J Clin Oncol 2006;24(35):5528-5535.
2. Konety BR. Molecular markers in bladder cancer: a critical appraisal. Urol Oncol 2006;24(4):326-337.
3. van Rhijn BWG, van der Poel HG , van der Kwast TH. Urinary markers for bladder cancer surveillance: a systematic review. Eur Urol 2005;47(6):736-748.
4. Bergman J, Reznichek RC, Rajfer J. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings. BJU Int 2008;101(1): 26-29.
5. Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL, Sebo TJ, Cheville JC, Clayton AC, Krajnik KL, Ebert TA, Nelson RE, Burkhardt HM, Ramakumar S, Stewart CS, Pankratz VS, Lieber MM, Blute ML, Zincke H, Seelig SA, Jenkins RB, O'Kane DJ. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol 2002;167(5):2001-2006.
6. Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Zilberstien Y, Friberger A, Kidron D, Kaplan E, Lew S, Leibovitch I. Combined analysis of morphology and fl uorescence in situ hybridization signifi cantly increases accuracy of bladder cancer detection in voided urine samples. Urology 2005;66(6):1354-1359.
7. Gudjonsson S, Isfoss BL, Hansson K, Domanski AM, Warenholt J, Soller W, Lundberg LM, Liedberg F, Grabe M, Månsson W. The value of UroVysion assay for surveillance of non-muscleinvasive bladder cancer. Eur Urol 2008;54(2):402-408.
8. Moonen PM, Merkx GF, Peelen P, Karthaus HF, Smeets DF, Witjes JA. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer. Eur Urol 2007;51(5):1275-1280.
9. Nieder AM, Soloway MS, Herr HW. Should we abandon the FISH test? Eur Urol 2007;51(6):1469-1471.
10. Lotan Y, Bensalah K, Ruddell T, Shariat SF, Sagalowsky AI, Ashfaq R. Prospective evaluation of the clinical usefulness of refl ex fl uorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder. J Urol 2008;179(6):2164-2169.
11. Kipp BR, Halling KC, Campion MB, Wendel AJ, Karnes RJ, Zhang J, Sebo TJ. Assessing the value of refl ex fl uorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocal. J Urol 2008; 179(4):1296-1301.
12. Matzkin H, Moinuddin SM, Soloway MS. Value of urine cytology versus bladder washing in bladder cancer. Urology 1992;39(3):201-203.
13. El-Bolkainy MN. Cytology of bladder carcinoma. J Urol 1980;124(1):20-22.
14. Sarosdy MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L, Zadra J, Burzon D, Osher G, Bridge JA, Anderson S, Johansson SL, Lieber M, Soloway M, Flom K. Clinical evaluation of a multitarget fl uorescent in situ hybridization assay for detection of bladder cancer. J Urol 2002;168(5):1950-1954.
15. Veeramachaneni R, Nordberg ML, Shi R, Herrera GA, Turbat- Herrera EA. Evaluation of fl uorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol 2003;28(6):301-307.
16. Kipp BR, Karnes RJ, Brankley SM, Harwood AR, Pankratz VS, Sebo TJ, Blute MM, Lieber MM, Zincke H, Halling KC. Monitoring intravesical therapy for superfi cial bladder cancer using fl uorescence in situ hybridization. J Urol 2005;173(2): 401-404.
17. Gofrit ON, Zorn KC, Silvestre J, Shalhav AL, Zagaja GP, Msezane LP, Steinberg GD. The predictive value of multi-targeted fl uorescent in-situ hybridization in patients with history of bladder cancer. Urol Oncol 2008;26(3):246-249.